Category Research Gap

Considerations for a demonstration pooled fund for R&D based on CEWG recommendations

January 13, 2017 · by · in NTDs, Research Gap · Leave a comment

Tool to assess disparity between resources dedicated to a disease and its relative burden on society

April 11, 2016 · by · in Research Gap · Leave a comment

Original de-linkage proposal

October 14, 2014 · by · in De-linkage examples, Research Gap, UAEM Basic references · Leave a comment

US public research (NIH) translates into higher health impact than private research

February 27, 2014 · by · in Research Gap, Universities vs Industry · Leave a comment

Econ review supporting feasibility of NTD R&D using push and pull mechanisms

February 27, 2014 · by · in NTDs, Research Gap · Leave a comment

4% of drugs registered 2000-11 for NTDs; 4 NCEs

December 10, 2013 · by · in NTDs, Research Gap · Leave a comment

Lots of HIV R&D, but only 0.1% for developing-country specific versions (G-FINDER)

November 26, 2013 · by · in NTDs, Research Gap · Leave a comment

ND R&D highly and unequally concentrated (G-FINDER)

November 26, 2013 · by · in NTDs, Research Gap · Leave a comment

Stiglitz outlining the need for new R&D mechanisms

November 25, 2013 · by · in NTDs, Research Gap · Leave a comment

NTD R&D funding comes from a small number of rich nations/charities

November 25, 2013 · by · in NTDs, Research Gap · Leave a comment

Original source of the “90/10 gap” (!)

November 4, 2013 · by · in Research Gap, UAEM Basic references · Leave a comment

1% of global R&D investments are for NTDs

November 4, 2013 · by · in Research Gap, UAEM Basic references · 3 Comments

Most innovative drugs are developed by Unis & Biotech

October 26, 2013 · by · in Research Gap, UAEM Basic references · 1 Comment

EU commission recognises failure in innovation

October 25, 2013 · by · in Pharma general, Research Gap · Leave a comment